Page 16 - Markets News

India VIX at 15-month low as market stays calm; muted volatility to persist

India VIX, the measure of market volatility in the domestic market, has fallen for the third straight month and is down 37 per cent so far since May

Risky options: Sebi should continue to educate retail investors carefully

A large number of retail traders dabble in futures & options (F&Os), drawn by high leverage and hopes of high returns

Street Signs: Nifty adrift in choppy waters, IFSCA nets ghost firms, more

Nifty logs third straight weekly drop amid earnings jitters; IFSCA takes action against ghost firms in GIFT City; IPO pipeline swells ahead of July 31 deadline

IPO-bound Indiqube Spaces' net loss narrows to ₹140 crore in FY25

Indiqube Spaces narrows its FY25 net loss to ₹139.61 crore, improving from the previous year. The company plans to raise ₹700 crore through its upcoming IPO opening July 23, 2025

Tourism boom, rising spend give wings to travel companies' IPO plans

Last week, airport quick service restaurant player Travel Food Services listed on BSE to raise Rs 2,000 crore

NSDL plans to start taking investor orders for IPO from next week

The expected proceeds exceed the approximately $400 million estimated by people familiar with the matter in June

Factor fund launches shift to active space with momentum, multi-factor

Mutual funds are expanding from passive to active factor-based offerings, launching momentum and multi-factor funds as quant strategies gain industry-wide traction

Sebi fines Prabhudas Lilladher ₹11 lakh for violating market norms

Capital markets regulator Sebi has levied a fine of Rs 11 lakh on Prabhudas Lilladher after finding the financial services firm in violation of several regulatory provisions, including misuse of client funds and incorrect margin reporting. The order came after the Securities and Exchange Board of India (Sebi) along with the exchanges NSE, BSE and MCX carried out a comprehensive joint inspection of Prabhudas Lilladher Pvt Ltd. The inspection period was from April 1, 2021, to October 31, 2022. One of the major findings was the alleged misuse of client funds on three occasions, where the net available balance (G) was negative, peaking at a shortfall of Rs 1.89 crore, thereby violating breach of market norms, the regulator said in the order on Wednesday. Further, violations included incorrect reporting of peak ledger balance in cash & cash equivalent, client registration process, and analysis of weekly enhanced supervision data, as per the order. Additionally, Sebi also found that the

How to build a smart portfolio? Dhiraj Relli of HDFC Securities suggests

Selecting ETFs with high liquidity and low tracking error is essential to ensure efficient execution and minimised deviation from benchmark indices

Gift City may see its first IPO soon, marking a new era for unlisted firms

Ed-tech firm among half dozen eyeing direct listing at financial hub

Anthem Biosciences IPO subscribed 73 pc on Day 1 of offer

The initial public offer of Anthem Biosciences Ltd got subscribed 73 per cent on the first day of share sale on Monday. The initial share sale received bids for 3,21,13,406 shares against 4,40,70,682 shares on offer, according to NSE data. Non-institutional Investors category garnered 1.55 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 58 per cent. The portion for Qualified Institutional Buyers (QIBs) received 37 per cent subscription. Anthem Biosciences has raised Rs 1,016 crore from anchor investors. The Rs 3,395-crore IPO of the Bengaluru-based firm will close on July 16. The price band has been fixed at Rs 540-570 per share. Since the IPO is entirely an offer-for-sale (OFS), the company will not receive any funds from the issue, and the proceeds will go to the selling shareholders. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operat

Near-term upsides from deal with AbbVie may be priced in Glenmark's stock

Glenmark's $700 million deal with AbbVie for ISB-2001 could unlock significant upside, though analysts note the potential is already priced in, with stock surging post-announcement

RBI issues draft directions for novation of OTC derivative contracts

Draft norms enable position transfer in OTC derivatives with consent and fair pricing; RBI mandates tripartite structure to ensure risk shift and regulatory adherence

MCX to launch India's first electricity futures contracts on July 10

The exchange will initially launch cash-settled contracts for the current and next three-month periods, but they will subsequently be available for all 12 calendar months, said MCX

F&O volumes fall as Jane Street crackdown affects derivatives market

On Monday, futures and options (F&O) turnover on the NSE was Rs 91.4 trillion, a 26 per cent drop from the average of the previous 12 Mondays

Debt securitisation volume rises to ₹49,000 crore in April-June quarter

Total number of originators in these securitisations, wherein a lender hands over future receivables on a single or a bunch of loans to a new entity usually on a discount, was around 90, Crisil report

Sebi to upgrade surveillance against derivatives manipulation: Chairman

Sebi chief Tuhin Kanta Pandey said the regulator is boosting its oversight days after banning US-based Jane Street for manipulating the Nifty Bank index

Equity capital market fees rise even as mobilisation dips in H12025

This rise came despite a 16 per cent drop in funds raised, with domestic ECM totalling $25.7 billion compared to a record $30.8 billion in H1 2024

HDB Financial Services jumps 13% on debut, valued at ₹69,704 crore

HDB Financial Services gains over 13 per cent on market debut with Rs 69,704 crore valuation after strong IPO demand, though RBI's stake cap proposal could weigh on outlook

Street signs: Nifty eyes 26K, demat flood breaks levee, HDB IPO fork

At the start of June, India's domestic markets were just 3 million dematerialised (demat) accounts short of the 200 million milestone